IP Library Granted Patent US 8,038,927
Granted Patent B2
US 8,038,927 · App. 12/690,185 · Granted Oct 18, 2011

Methods for making oxidation resistant polymeric material

Assignees: The General Hosital Corporation; Cambridge Polymer Group, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,038,927
App. No.
12/690,185
Granted
Oct 18, 2011
Kind
B2
Abstract

The present invention relates to methods for making oxidation resistant medical devices that comprise polymeric materials, for example, ultra-high molecular weight polyethylene (UHMWPE). The invention also provides methods of making antioxidant-doped medical implants, for example, doping of medical devices containing cross-linked UHMWPE with vitamin E by diffusion and materials used therein.

Claims (35)

1. A method for oxidative stabilization of cross-linked ultrahigh molecular weight polyethylene (UHMWPE), wherein the method comprises:

(a) providing consolidated UHMWPE that has been irradiated with ionizing radiation to form cross-links in the UHMWPE;

(b) doping the consolidated UHMWPE from step (a) with an antioxidant by diffusion, under ambient pressure, and at a temperature below the melting point of the UHMWPE; and

(c) annealing the antioxidant-doped consolidated and cross-linked UHMWPE by heating at a temperature below its melting point under ambient pressure,

wherein the method provides a consolidated and cross-linked UHMWPE that is oxidatively stable and can be used in a medical implant.

2. The method of claim 1 , wherein the doping is carried out by soaking the consolidated and cross-linked UHMWPE in an antioxidant for about an hour to about 16 hours.

3. The method of claim 1 , wherein the doping is carried out by diffusion with an antioxidant under an inert gas atmosphere.

4. The method of claim 1 , wherein the antioxidant is heated to about 100° C. or more and the doping is carried out at 100° C. or more.

5. The method of claim 1 , wherein the antioxidant is

Alpha- or delta-tocopherol,

propyl, octyl, or dedocyl gallates,

lactic, citric or tartaric acids, or any salt thereof,

orthophosphates, or

tocopherol acetate.

6. The method of claim 1 , wherein the antioxidant is vitamin E.

7. A method for oxidative stabilization of cross-linked ultrahigh molecular weight polyethylene (UHMWPE), wherein the method comprises:

a) providing consolidated UHMWPE that has been irradiated with ionizing radiation to form cross-links in the UHMWPE;

(b) doping the consolidated UHMWPE from step (a) with an antioxidant by diffusion, under ambient pressure, and at a temperature below the melting point of the UHMWPE;

(c) annealing the antioxidant-doped consolidated and cross-linked UHMWPE by heating at a temperature below its melting point under ambient pressure,

wherein the method provides a consolidated and cross-linked UHMWPE that is oxidatively stable and can be used in a medical implant;

(d) machining the antioxidant-doped consolidated and cross-linked UHMWPE, thereby forming the medical implant comprising oxidatively stable UHMWPE;

(e) packaging the medical implant comprising oxidatively stable UHMWPE; and

(f) sterilizing the packaged medical implant by gamma radiation.

8. The method of claim 7 , wherein the gamma sterilization is carried out in inert gas or vacuum.

9. The method of claim 7 , wherein the doping is carried out by soaking the consolidated and cross-linked UHMWPE in an antioxidant for about an hour to about 16 hours.

10. The method of claim 7 , wherein the antioxidant is heated to about 100° C. or more and the doping is carried out at 100° C. or more.

11. The method of claim 7 , wherein the doping is carried out by diffusion with an antioxidant under an inert gas atmosphere.

12. The method of claim 7 , wherein the antioxidant is

Alpha- or delta-tocopherol,

propyl, octyl, or dedocyl gallates,

lactic, citric or tartaric acids, or any salt thereof,

orthophosphates, or

tocopherol acetate.

13. The method of claim 7 , wherein the antioxidant is vitamin E.

14. The method according to claim 7 , wherein the medical implant forms all or part of one selected from the group consisting of acetabular liner, shoulder glenoid, patellar component, finger joint component, ankle joint component, elbow joint component, wrist joint component, toe joint component, bipolar hip replacements, tibial knee insert, tibial knee inserts with reinforcing metallic and polyethylene posts, intervertebral discs, sutures, tendons, heart valves, stents, and vascular grafts.

Assignments (2)
CHANGE OF ADDRESS Recorded Apr 29, 2011
From: CAMBRIDGE POLYMER GROUP, INC.
To: CAMBRIDGE POLYMER GROUP, INC.
Reel/Frame 026205/0194 →
CHANGE OF NAME Recorded Apr 29, 2011
From: MASSACHUSETTS GENERAL HOSPITAL
To: THE GENERAL HOSPITAL CORPORATION
Reel/Frame 026205/0336 →
Continuity (4)
Continuation 11564594 · Nov 29, 2006
Continuation 10757551 · Jan 15, 2004
Provisional Application 60440389 · Jan 16, 2003
Related Publication 20110109017A1 · May 12, 2011